[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"needle-injury\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:needle-injury":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":31,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100605729","ultrasound-evaluation-of-hematoma-risk-after-needle-emg-in-patient-on-doac-therapy-100605729",false,"NCT07166302","Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy","U-HAND","Inclusion Criteria:\n\n* Subjects must understand the nature of the study and must provide signed and dated written informed consent prior to conducting any study-related procedures\n* Willing and able to comply with all protocol procedures\n* subjects confirmed the daily (and recent) intake od direct anticoagulants in strandard dosing.\n* no other antitrombotic drug therapy (e.g. acetylsalicyl acid, clopidogrel, ticagralol, low molecular weight heparin or second direct anticoagulant) is taken.\n\nExclusion Criteria:\n\n* Any clinically significant medical or psychiatric condition or medical history that, in the opinion of the investigator, would interfere with the subject's ability to participate in the study or increase the risk of participation for that subject\n* other antitrombotic drug therapy (e.g. acetylsalicyl acid, clopidogrel, ticagralol, low molecular weight heparin or second direct anticoagulant) is recently taken.","ALL",{"count":18,"type":19},70,"ESTIMATED","7 Days","OBSERVATIONAL","Approximately 30 minutes after needle EMG, patients who are taking direct oral anticoagulants (DOACs) will undergo an ultrasound examination to evaluate for the presence of possible intramuscular hematomas at the muscles where the EMG needle was inserted. These hematomas are considered a potential adverse effect of needle EMG.\n\nThe aim of the study is to determine whether needle EMG can be considered a safe procedure in this group of patients, without posing a risk of intramuscular hematoma formation.",[24,25,26,27,28,29,30],"Direct Acting Anticoagulant Adverse Reaction","Needle Injury","EMG","Peripheral Neuropathies","Mononeuropathies","Polyneuropathies","Neuromuscular Diseases (NMD)",[32,33,34,35],"electromyography","hematoma","ultrasonography","anticoagulants","RECRUITING","2025-09-03",{"date":39,"type":40},"2025-09-10","ACTUAL",{"date":42,"type":19},"2025-09",{"date":44,"type":19},"2026-12-31",{"name":46,"class":47},"Masaryk University","OTHER",{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":55,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":58,"conditions":59,"keywords":64,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":77},"100491450","a-cross-sectional-observational-study-on-retained-drug-needle-fragments-in-people-who-use-intravenous-drugs-100491450","NCT05679284","A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs","The Prevalence and Predisposing Factors to Retained Drug Needle Fragments in People Who Inject Drugs: a Protocol for a Cross-sectional Observational Study","Inclusion Criteria:\n\n* History of intravenous drug use\n* Current treatment of the drug abuse problem at a local low-threshold drug abuse service unit or primary health care centre.\n* Adherence to fill in the questionnaire\n* Participation to X-ray imaging of injection sites\n\nExclusion Criteria:\n\n* No history of intravenous drug use\n* Does not adhere to fill in the questionnaire or refuses X-ray imaging\n* Pregnancy\n* Underage (18 years old)","18 Years",{"count":57,"type":19},100,"In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature has described numerous case reports of people who inject drugs (PWIDs) and have retained needle fragments. The prevalence of the condition is not known, and the researchers therefore aim to perform the first cross-sectional study of PWIDs to estimate how common needle fragment retentions are and what their risk factors are in this population.",[60,61,25,62,63],"Drug Abuse, Intravenous","Substance Dependence","Soft Tissue Injuries","Foreign Bodies",[65,66,67],"Intravenous drug use","needle retention","needle fragment","2023-05-30",{"date":70,"type":40},"2023-06-01",{"date":72,"type":40},"2023-05-25",{"date":74,"type":19},"2028-11-15",{"name":76,"class":47},"Tampere University Hospital",1]